Liver Cancer Trial, Recruiting NCT06523608 Sponsor: University Hospital Muenster Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06523608
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are admitted to hospital or attending as an outpatient with advanced chronic liver disease, diagnosed based on a standard set of medical guidelines called the BAVENO criteria

Who may not be able to join:

  • People who are pregnant
  • People who are under 18 years of age
  • People who currently have cancer, except for certain common types of non-melanoma skin cancer
  • People who have, or have had, serious diseases affecting other organs — for example, kidney failure requiring dialysis, significant heart problems, severe chronic lung disease, or serious neurological or psychiatric conditions
  • People who are HIV positive
  • People who have previously received a liver transplant or any other organ transplant
  • People who are unwilling to participate, or who are unable to provide written consent and have no legal representative able to consent on their behalf, and where recovery of the ability to consent is considered unlikely
  • People whose doctor decides, for clinical reasons, that participation would not be appropriate — for example, if the treating doctor believes the person would not be able to follow the trial schedule

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jonel Trebicka, Prof. Dr. med., Department of Internal Medicine B, University Hospital Muenster, Muenster, Germany

Phone: +49 02518359689

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Muenster
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
1 September 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Mortality; Liver transplantation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov